Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Integra LifeSciences is a leading global medical technology company that specializes in regenerative tissue technologies and neurological solutions. Founded in 1989 by Dr. Richard Caruso, the company pioneered the use of collagen-based matrices to facilitate the body's natural healing process and tissue regeneration. Its extensive product portfolio includes market-leading brands such as the Integra Dermal Regeneration Template, DuraGen, and CUSA, which are widely used in neurosurgery, wound care, and reconstructive surgery. The company operates through two primary segments: Codman Specialty Surgical and Tissue Technologies, serving millions of patients worldwide. Integra is headquartered in Princeton, New Jersey, and is a publicly traded entity on the NASDAQ exchange.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Rick Caruso.